FTC Proposes Settlement On Firms’ Genetic Skin-Care, Supplement Claims
This article was originally published in The Rose Sheet
Executive Summary
GeneLink and foru International Corporation, which marketed a nutritional supplement and skin-care product system tailored to users’ unique genetic profiles, have agreed in a proposed FTC settlement to discontinue health claims that lack sufficient scientific backing.